U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499882) titled 'Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy' on March 19.
Brief Summary: The purpose of this observational, data collection, research is to evaluate if ziconotide, a commercially approved medication given by a FDA cleared intrathecal pump, for chronic pain is effective in the treatment of chemotherapy-induced peripheral neuropathy (CIPN) a common and often long-lasting side effect of cancer treatment.
Study Start Date: May 02
Study Type: OBSERVATIONAL
Condition:
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Intervention:
DRUG: Ziconotide
Real world evidence trial. Patients that are on intrathecal...